Gezondheidszorg aandelen: kwaliteit, waardering en dividend
178 aandelen met een openbare koerspagina — kwaliteitsscore, koers/winst, dividendrendement en omzetgroei naast elkaar
Gezondheidszorg in cijfers
178 aandelen, medianenFarmacie en medische technologie kennen hoge marges, maar patenten verlopen en onderzoek kan mislukken. Biotechbedrijven zonder omzet krijgen geen score.
Meest bezeten door leden in deze sector
alleen aandelen met minstens 5 bezitters| Symbool | Naam | Bezitters | Kwaliteitsscore | K/W | Dividendrendement |
|---|---|---|---|---|---|
| HIMS | Hims Hers Health Inc | 124 leden | 40 | – | – |
| NVO | Novo Nordisk A/S | 89 leden | 86 | 10,7× | 4,2 % |
| PHARM | Pharming Group NV | 76 leden | 40 | 91,7× | – |
| NOV | Novo Nordisk A/S | 70 leden | 97 | 10,7× | 31,2 % |
| NOVO-B | Novo Nordisk A/S | 66 leden | 86 | 10,7× | 4,2 % |
| UNH | UnitedHealth Group Incorporated | 53 leden | 48 | 24,2× | 2,4 % |
| PHIA | Koninklijke Philips NV | 45 leden | 24 | 19,0× | 4,0 % |
| JNJ | Johnson & Johnson | 36 leden | 70 | 31,4× | 1,9 % |
| PFE | Pfizer Inc | 31 leden | 45 | 36,4× | 6,2 % |
| GXE | Galapagos NV | 31 leden | 30 | 2,8× | – |
Aantal leden van De Belegger met het aandeel in de portefeuille; geen bedragen. Populair zegt niets over de kwaliteit of de waardering.
Alle 178 aandelen in Gezondheidszorg
op kwaliteitsscore, zonder score onderaan| Symbool | Naam | Kwaliteitsscore | K/W | Dividendrendement | Omzetgroei/jr | Bezitters |
|---|---|---|---|---|---|---|
| VEEV | Veeva Systems Inc Class A | 100 | 42,7× | – | 14,0 % | 8 leden |
| NOV | Novo Nordisk A/S | 97 | 10,7× | 31,2 % | 20,3 % | 70 leden |
| MEDP | Medpace Holdings Inc | 97 | 36,0× | – | 20,1 % | – |
| ISRG | Intuitive Surgical Inc | 96 | 45,1× | – | 17,4 % | 15 leden |
| REGN | Regeneron Pharmaceuticals Inc | 91 | 19,4× | 0,5 % | 5,6 % | 6 leden |
| QTTB | Q32 Bio Inc | 87 | 3,4× | – | 100,7 % | – |
| NOVO-B | Novo Nordisk A/S | 86 | 10,7× | 4,2 % | 20,4 % | 66 leden |
| LLY | Eli Lilly and Company | 86 | 38,8× | 0,6 % | 31,7 % | 23 leden |
| NVO | Novo Nordisk A/S | 86 | 10,6× | 4,1 % | 20,4 % | – |
| NVO | Novo Nordisk A/S | 86 | 10,7× | 4,2 % | 20,4 % | 89 leden |
| VRTX | Vertex Pharmaceuticals Inc | 86 | 29,6× | – | 10,6 % | – |
| AZN | AstraZeneca PLC | 83 | 24,9× | 1,9 % | 9,8 % | – |
| NOVA | Novo Nordisk A/S | 83 | 10,7× | 31,2 % | 20,4 % | 6 leden |
| BSX | Boston Scientific Corporation | 81 | 17,6× | – | 16,5 % | – |
| HALO | Halozyme Therapeutics Inc | 81 | 33,0× | – | 28,4 % | – |
| LLY | Eli Lilly and Company | 79 | 38,6× | 0,7 % | 31,7 % | – |
| ARGX | Argen-X | 76 | 38,0× | – | 116,2 % | 13 leden |
| ZTS | Zoetis Inc | 76 | 11,7× | 2,8 % | 5,4 % | 10 leden |
| ZEAL | Zealand Pharma A/S | 76 | 7,2× | – | 345,8 % | – |
| INMD | InMode Ltd | 75 | 11,9× | – | -6,6 % | 5 leden |
| BSX | Boston Scientific Corp | 73 | 17,6× | – | 16,5 % | 8 leden |
| NVS | Novartis AG ADR | 72 | 21,2× | 3,4 % | 8,0 % | – |
| JNJ | Johnson & Johnson | 70 | 31,4× | 1,9 % | 5,6 % | 36 leden |
| TMDX | TransMedics Group Inc | 68 | 22,4× | – | 86,4 % | – |
| GILD | Gilead Sciences Inc | 67 | – | 2,1 % | 2,6 % | – |
| RGEN | Repligen Corporation | 65 | 242,3× | – | -2,7 % | – |
| R9U2 | Green Thumb Industries Inc | 65 | 13,4× | – | 4,9 % | – |
| GS71 | GSK plc | 64 | 15,9× | 3,1 % | 3,7 % | – |
| FAGR | Fagron NV | 64 | 17,6× | 1,8 % | 11,7 % | 9 leden |
| OSCR | Oscar Health Inc | 63 | 24,7× | – | 41,6 % | 16 leden |
| COLO-B | Coloplast A/S | 61 | 34,1× | 5,5 % | 7,3 % | – |
| ABT | Abbott Laboratories | 59 | 33,2× | 2,4 % | 0,5 % | 12 leden |
| MCK | McKesson Corporation | 59 | 23,5× | 0,4 % | 13,4 % | – |
| EL | EssilorLuxottica S. A. | 59 | 26,0× | 2,8 % | 5,2 % | – |
| LKFT | LAKEFRONT BIOTHERAPEUTICS NV | 59 | 2,8× | – | 30,1 % | – |
| SAN | Sanofi SA | 58 | 22,9× | 5,5 % | 5,0 % | 8 leden |
| ABBV | AbbVie Inc | 57 | 74,6× | 2,6 % | 1,8 % | 29 leden |
| SNW | Sanofi | 56 | 22,9× | 5,5 % | -1,3 % | – |
| CAH | Cardinal Health Inc | 55 | 31,2× | 0,9 % | 7,4 % | – |
| NURS | Hydreight Technologies Inc | 55 | 23,9× | – | 102,4 % | – |
| HYDTF | Hydreight Technologies Inc. | 55 | 24,3× | – | 102,4 % | 12 leden |
| SNYNF | Sanofi | 54 | 24,2× | 4,8 % | 2,7 % | – |
| 2LYA | High Tide Inc | 53 | – | – | 18,5 % | 25 leden |
| COO | The Cooper Companies, Inc | 52 | 19,0× | – | 7,4 % | – |
| IBAB | Ion Beam Applications SA | 50 | 18,6× | 1,6 % | 19,7 % | – |
| UNH | UnitedHealth Group Incorporated | 48 | 24,2× | 2,4 % | 11,4 % | 53 leden |
| UNH | UnitedHealth Group Incorporated | 48 | 24,1× | 2,7 % | 11,6 % | 12 leden |
| TMO | Thermo Fisher Scientific Inc | 48 | 35,1× | 0,3 % | -0,3 % | – |
| OPCH | Option Care Health Inc | 47 | 18,4× | – | 12,7 % | – |
| LFMD | LifeMD Inc | 47 | – | – | 17,7 % | 7 leden |
| MDT | Medtronic PLC | 46 | 22,7× | 3,1 % | 5,2 % | – |
| CRON | Cronos Group Inc | 46 | 17,3× | – | 19,4 % | – |
| MEDCL | Medincell SA | 46 | – | – | 25,2 % | – |
| IVA | Inventiva S.A | 46 | – | – | -28,3 % | – |
| PFE | Pfizer Inc | 45 | 36,4× | 6,2 % | -14,6 % | 31 leden |
| PFE | Pfizer Inc | 44 | 36,3× | 7,1 % | -14,6 % | 10 leden |
| NRXS | Neuraxis, Inc. | 43 | – | – | 10,0 % | – |
| HIMS | Hims Hers Health Inc | 40 | – | – | 64,6 % | 124 leden |
| PHARM | Pharming Group NV | 40 | 91,7× | – | 22,3 % | 76 leden |
| AFX | Carl Zeiss Meditec AG | 38 | 21,5× | 1,9 % | 5,4 % | – |
| ELV | Elevance Health Inc | 37 | 18,2× | 1,7 % | 8,3 % | – |
| MRNA | Moderna Inc | 35 | – | – | -53,1 % | 5 leden |
| NTRA | Natera Inc | 35 | – | – | 41,1 % | – |
| TWST | Twist Bioscience Corp | 35 | – | – | 22,8 % | – |
| CRSP | Crispr Therapeutics AG | 35 | – | – | 100,4 % | 13 leden |
| BEAM | Beam Therapeutics Inc | 35 | – | – | 31,9 % | 5 leden |
| RXRX | Recursion Pharmaceuticals Inc | 35 | – | – | 23,5 % | – |
| SOPH | Sophia Genetics SA | 35 | – | – | 17,6 % | – |
| RXST | Rxsight Inc | 35 | – | – | 40,0 % | – |
| ONWD | Onward Medical N.V. | 35 | – | – | 22,1 % | 11 leden |
| HYL | Hyloris Developmentsen Sa | 35 | – | – | 34,7 % | – |
| TNON | Tenon Medical Inc | 35 | – | – | 78,7 % | – |
| SGFY | Signify Health Inc | 34 | 70,9× | 0,0 % | 17,1 % | – |
| SDGR | Schrodinger Inc | 32 | – | – | 12,2 % | – |
| HITI | High Tide Inc | 32 | – | – | 18,5 % | 11 leden |
| SCYX | Scynexis Inc | 31 | – | – | 59,4 % | – |
| SINT | SINTX Technologies Inc | 31 | – | – | 19,2 % | – |
| GXE | Galapagos NV | 30 | 2,8× | – | 30,1 % | 31 leden |
| 2H51 | Ocugen Inc | 30 | – | – | 21,1 % | – |
| OWLT | Owlet Inc | 30 | – | – | 15,2 % | – |
| NYXH | Nyxoah | 30 | – | – | 48,1 % | 7 leden |
| APRE | Aprea Therapeutics Inc | 30 | – | – | -98,4 % | – |
| EVT | Evotec SE | 29 | – | – | 1,6 % | – |
| HROW | Harrow Health Inc | 27 | – | – | 45,4 % | 6 leden |
| AORT | Artivion Inc | 26 | – | – | 12,0 % | – |
| PHIA | Koninklijke Philips NV | 24 | 19,0× | 4,0 % | 0,0 % | 45 leden |
| ACB | Aurora Cannabis Inc | 24 | – | – | 12,7 % | – |
| TEVA | Teva Pharma Industries Ltd ADR | 23 | 65,0× | – | 5,0 % | – |
| ALT | Altimmune Inc | 23 | – | – | 420,0 % | 6 leden |
| GH | Guardant Health Inc | 21 | – | – | 29,8 % | – |
| TEM | Tempus AI, Inc. Class A Common Stock | 21 | – | – | 58,3 % | 18 leden |
| NTLA | Intellia Therapeutics Inc | 21 | – | – | 9,1 % | 5 leden |
| RARE | Ultragenyx | 21 | – | – | 22,8 % | – |
| AUTL | Autolus Therapeutics Ltd | 21 | – | – | 130,2 % | – |
| OCGN | Ocugen Inc | 21 | – | – | 21,1 % | – |
| CCCC | C4 Therapeutics Inc | 20 | – | – | 5,0 % | – |
| ABCL | Abcellera Biologics Inc | 18 | – | – | -46,3 % | 20 leden |
| QURE | Uniqure NV | 18 | – | – | -46,7 % | – |
| ABSI | Absci Corp | 18 | – | – | -21,3 % | – |
| ATYR | aTyr Pharma, Inc. | 18 | – | – | -73,7 % | – |
| TLRY | Tilray Inc | 14 | – | – | 2,7 % | 9 leden |
| BAYN | Bayer AG NA | 12 | – | 0,2 % | -3,5 % | 11 leden |
| VVOS | Vivos Therapeutics Inc | 9 | – | – | 2,9 % | – |
| MICR | MICR | 3 | – | – | 8,8 % | – |
| 3G0 | Altimmune Inc | 0 | – | – | 420,0 % | – |
| SEQUA | Sequana Medical NV | 0 | – | – | -34,1 % | 5 leden |
| WOK | WORK Medical Technology Group LTD Ordinary Shares | 0 | – | – | -20,7 % | – |
| LLY | Eli Lilly and Company | – | 38,2× | 0,6 % | 47,7 % | – |
| NOVO | Novo Nordisk CDR (CAD Hedged) | – | 3,3× | 63,7 % | 0,0 % | – |
| MRK | Merck & Company Inc | – | 117,5× | 2,3 % | 3,1 % | 5 leden |
| NOVN | Novartis AG | – | 21,0× | 4,0 % | 9,5 % | – |
| BMY | Bristol-Myers Squibb Company | – | 13,9× | 4,0 % | 1,5 % | 9 leden |
| CVS | CVS Health Corp | – | 23,4× | 2,9 % | 7,6 % | – |
| HIMS | Hims & Hers Health, Inc. | – | – | – | 64,6 % | – |
| HCA | HCA Healthcare, Inc. | – | 14,4× | 0,7 % | 7,9 % | – |
| ARGX | argenx NV ADR | – | 37,8× | – | 116,2 % | – |
| 0QF | Moderna, Inc. | – | – | – | -53,3 % | – |
| INSM | Insmed Inc | – | – | – | 35,2 % | – |
| BAX | Baxter International Inc | – | – | 0,8 % | 5,3 % | – |
| MDGL | Madrigal Pharmaceuticals Inc | – | – | – | 71,2 % | – |
| ARWR | Arrowhead Pharmaceuticals Inc | – | – | – | 171,0 % | – |
| YDO1 | Madrigal Pharmaceuticals Inc | – | – | – | 71,2 % | – |
| PCVX | Vaxcyte Inc | – | – | – | 0,0 % | – |
| TUB | Tubize-Fin | – | 80,1× | 0,6 % | 0,0 % | – |
| 82W | HIMS+HERS HERS A DL-0001 | – | – | – | 64,6 % | 17 leden |
| DFTX | Definium Therapeutics, Inc. | – | – | – | 0,0 % | – |
| 61L0 | SECTRA AB | – | 89,8× | 0,0 % | 14,7 % | – |
| BLLN | BillionToOne, Inc. Class A Common Stock | – | 142,0× | – | 64,4 % | – |
| CELC | Celcuity LLC | – | – | – | 0,0 % | – |
| VKTX | Viking Therapeutics Inc | – | – | – | 0,0 % | 5 leden |
| ZLDPF | Zealand Pharma A/S | – | 7,2× | – | 345,5 % | – |
| VERA | Vera Therapeutics Inc | – | – | – | 0,0 % | – |
| SLS | Sellas Life Sciences Group Inc | – | – | – | -82,5 % | 14 leden |
| GENB | Generate Biomedicines, Inc. Common Stock | – | – | – | -37,7 % | 5 leden |
| UFPT | UFP Technologies Inc | – | 29,9× | – | 19,4 % | – |
| CMPS | Compass Pathways Plc | – | – | – | 0,0 % | 5 leden |
| NUVB | Nuvation Bio Inc | – | – | – | 555,6 % | – |
| KLRA | Kailera Therapeutics, Inc. Common Stock | – | – | – | 0,0 % | – |
| NANO | Nanobiotix S.A | – | – | – | 83,8 % | – |
| DRTS | Alpha Tau Medical Ltd | – | – | – | 0,0 % | – |
| ORIC | Oric Pharmaceuticals Inc | – | – | – | 0,0 % | – |
| OMDA | Omada Health, Inc. Common Stock | – | 30,5× | – | 42,9 % | – |
| TDOC | Teladoc Inc | – | – | – | 1,7 % | 5 leden |
| SANA | Sana Biotechnology Inc | – | – | – | 0,0 % | – |
| HELP | Cybin Inc. Common Stock | – | – | – | 0,0 % | – |
| ALT | Altimmune Inc | – | – | – | 420,0 % | – |
| DRUG | Bright Minds Biosciences Inc | – | – | – | 0,0 % | – |
| KIDS | Orthopediatrics Corp | – | – | – | 24,6 % | – |
| PACB | Pacific Biosciences of California | – | – | – | 7,6 % | – |
| OCGN | Ocugen Inc | – | – | – | 8,4 % | – |
| PRQR | ProQR Therapeutics BV | – | – | – | 62,0 % | – |
| PLX | Protalix Biotherapeutics Inc | – | 11,7× | – | 3,5 % | – |
| QSI | QuantumSi Inc | – | – | – | 74,4 % | 9 leden |
| CDXS | Codexis Inc | – | – | – | -20,2 % | – |
| OPRX | OPTIMIZERx Corp | – | 29,2× | – | 20,6 % | 5 leden |
| BMEA | Biomea Fusion Inc | – | – | – | 0,0 % | 8 leden |
| ENGN | enGene Holdings Inc. Common Stock | – | – | – | 0,0 % | – |
| CCLD | CareCloud, Inc. | – | 31,0× | – | -4,6 % | – |
| OSTX | OS Therapies Incorporated | – | – | – | 0,0 % | – |
| ZOMDF | Zomedica Corp. | – | – | – | 19,2 % | 13 leden |
| MYO | Myomo Inc | – | – | – | 38,1 % | 6 leden |
| MDAI | Spectral AI Inc. | – | – | – | -8,2 % | – |
| MGX | Metagenomi, Inc. Common Stock | – | – | – | -69,8 % | 7 leden |
| CRVO | CervoMed Inc. | – | – | – | -99,6 % | – |
| MIRA | MIRA Pharmaceuticals, Inc. Common Stock | – | – | – | 0,0 % | – |
| VVY | Vivoryon Therapeutics NV | – | – | – | 0,0 % | 9 leden |
| BNGO | Bionano Genomics Inc | – | – | – | 0,8 % | 7 leden |
| BCDA | Biocardia Inc | – | – | – | -100,0 % | – |
| ENLV | Enlivex Therapeutics Ltd | – | 0,0× | – | 0,0 % | – |
| MEDS | DataMEDS AI, Inc. | – | – | – | -10,7 % | – |
| POXEL | Poxel SA | – | – | – | -20,9 % | – |
| VNRX | Volitionrx Ltd | – | – | – | 78,0 % | – |
| IVF | INVO Fertility, Inc. | – | 0,0× | – | 102,6 % | – |
| DOGP | Dogecoin Cash, Inc. | – | 0,0× | – | -22,0 % | – |
| SDCCQ | SmileDirectClub Inc. | – | – | – | -19,1 % | – |
| TG40 | Oxurion NV | – | – | – | -2,3 % | 6 leden |
| ISCNF | Isracann Biosciences Inc | – | – | – | -50,6 % | – |
| DHT | Hataphar | – | – | – | 0,0 % | – |
Dagelijks vernieuwd uit onze eigen cijfers · Geen advies. Alle sectoren ›
Elke pagina is gratis te lezen. Leden van De Belegger zien op de aandelenpagina ook hun eigen positie, de vergelijking met de andere bezitters, de kalender met cijferdata en ex-dividend en de berichten van andere leden.
Zoek een aandeel in de app (inloggen)Gratis accountWord lid van De Belegger